Literature DB >> 6468375

Comparison of Clostridium botulinum toxins type D and C1 in molecular property, antigenicity and binding ability to rat-brain synaptosomes.

S Murayama, B Syuto, K Oguma, H Iida, S Kubo.   

Abstract

Botulinum type D neurotoxin was purified 950-fold from the culture supernatant with an overall yield of 32%. The purified toxin had a specific toxicity of 5.8 X 10(7) mouse minimal lethal dose per mg of protein and a relative molecular mass of 140000. The purified toxin had a di-chain structure consisting of heavy and light chains with relative molecular masses of 85000 and 55000, respectively, linked by one disulfide bond. These subunits had different amino acid compositions and antigenicities. A similarity in molecular constructions and amino acid compositions was observed between type D and type C1 toxins as well as between their subunits. Among the seven kinds of monoclonal antibodies against type D toxin, six reacted with the heavy chain of type D toxin, while one of the six also reacted with the heavy chain of type C1 toxin and neutralized the toxicities of the two toxins. The other one of monoclonal antibodies reacted with the light chains of both toxins. This evidence indicates that both toxins have common antigenic sites on their heavy and light chains and that the antigenic site on the heavy chain may contribute to the neutralization of both toxins by antibody. The binding of type D toxin to rat brain synaptosomes was examined by use of 125I-labelled type D toxin. The binding was competitively inhibited not only by unlabelled type D and C1 toxins, but also by the heavy chains of both toxins, however, it was not inhibited by the light chain of type D toxin. These results suggest that the toxin receptors on synaptosomal membrane are common for type D and C1 toxins, and that the heavy chain contributes to the binding of toxin to synaptosomes and the structure of the binding sites on the heavy chains of both toxins is quite similar.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6468375     DOI: 10.1111/j.1432-1033.1984.tb08312.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

Review 1.  Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use.

Authors:  P Hambleton
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

2.  Molecular diversity of neurotoxins from Clostridium botulinum type D strains.

Authors:  K Moriishi; B Syuto; S Kubo; K Oguma
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

Review 3.  Botulinum neurotoxin - from laboratory to bedside.

Authors:  K A Foster; H Bigalke; K R Aoki
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

4.  The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin.

Authors:  S Kozaki; Y Kamata; T Nagai; J Ogasawara; G Sakaguchi
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

5.  Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813.

Authors:  J Terajima; B Syuto; J O Ochanda; S Kubo
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

6.  Binding of Clostridium botulinum type C neurotoxin to different neuroblastoma cell lines.

Authors:  N Yokosawa; Y Kurokawa; K Tsuzuki; B Syuto; N Fujii; K Kimura; K Oguma
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.